Jul 22, 2026 04:30PM
Jul 22, 2026 04:30PM
Jul 10, 2026 11:23AM
Jul 10, 2026 11:23AM
May 30, 2026 08:00AM
Apr 20, 2026 06:45AM
Apr 20, 2026 06:45AM U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
Mar 19, 2026 06:45AM
Feb 27, 2026 10:04AM
Feb 27, 2026 10:00AM
Feb 23, 2026 05:00PM
Dec 17, 2025 06:45AM
Nov 21, 2025 01:24PM
Nov 21, 2025 01:24PM U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
Oct 19, 2025 04:15AM
Oct 18, 2025 10:30AM
Aug 12, 2025 05:30AM
Jul 17, 2025 12:00AM
Jul 17, 2025 12:00AM
Jul 10, 2025 06:45AM
May 22, 2025 05:05PM Astrellas and Pfizer's (PFE) announces results from Phase 3 study on XTANDI
May 22, 2025 05:00PM
Feb 13, 2025 10:00AM
Feb 12, 2025 06:32PM
Feb 10, 2025 05:01PM
Feb 10, 2025 05:00PM
Jan 8, 2025 06:30PM
Oct 10, 2024 06:51AM Pfizer’s TALZENNA® in Combination with XTANDI® Prolongs Overall Survival in Phase 3 TALAPRO-2 Trial
May 21, 2024 12:00AM
Jan 26, 2024 12:01PM
Jan 26, 2024 12:00PM
Jan 26, 2024 12:00PM
Jan 8, 2024 06:30PM
Jan 8, 2024 10:35AM
Dec 21, 2023 06:30PM Astellas Completes Acquisition of Propella Therapeutics
Dec 15, 2023 05:00PM
Nov 16, 2023 10:33PM
Nov 15, 2023 06:37PM
Aug 23, 2023 06:45AM
Jun 20, 2023 06:34PM
Apr 30, 2023 09:24PM
Apr 30, 2023 07:00PM Astellas Enters Into Definitive Agreement to Acquire Iveric Bio
Apr 30, 2023 07:00PM
Apr 29, 2023 10:45AM
Mar 16, 2023 07:30PM
Feb 19, 2023 06:30PM
Feb 16, 2023 10:00AM
Oct 4, 2022 06:45AM
Aug 18, 2022 02:30AM U.S. FDA Accepts Astellas' New Drug Application for Fezolinetant
Sep 20, 2021 05:46AM

1,211,968 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All